
|Videos|August 24, 2021
42-Year-Old Female With Itchy Eyes
This program is sponsored by Eyevance Pharmaceuticals, a Santen company.
Advertisement
Mark S. Milner, MD
Board-certified Ophthalmologist
Associate Clinical Professor, Yale University School of Medicine,
New Haven, Connecticut
Director of Cornea, Goldman Eye, Palm Beach Gardens, Florida
Co-Chief Medical Officer, Eyevance Pharmaceuticals, a Santen company
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
4
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
5














































.png)


